- Home
- NBY vs MTNB Comparison
NBY vs MTNB Comparison
Compare NBY & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- MTNB
- Stock Information
- Founded
- NBY 2000
- MTNB 2013
- Country
- NBY United States
- MTNB United States
- Employees
- NBY N/A
- MTNB N/A
- Industry
- NBY
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- NBY
- MTNB Health Care
- Exchange
- NBY Nasdaq
- MTNB Nasdaq
- Market Cap
- NBY 3.4M
- MTNB 3.1M
- IPO Year
- NBY 2007
- MTNB N/A
- Fundamental
- Price
- NBY $0.58
- MTNB $0.67
- Analyst Decision
- NBY Strong Buy
- MTNB Hold
- Analyst Count
- NBY 1
- MTNB 1
- Target Price
- NBY $0.85
- MTNB N/A
- AVG Volume (30 Days)
- NBY 67.8K
- MTNB 32.8K
- Earning Date
- NBY 05-08-2025
- MTNB 04-15-2025
- Dividend Yield
- NBY N/A
- MTNB N/A
- EPS Growth
- NBY N/A
- MTNB N/A
- EPS
- NBY N/A
- MTNB N/A
- Revenue
- NBY $9,781,000.00
- MTNB N/A
- Revenue This Year
- NBY $23.91
- MTNB N/A
- Revenue Next Year
- NBY $32.05
- MTNB N/A
- P/E Ratio
- NBY N/A
- MTNB N/A
- Revenue Growth
- NBY N/A
- MTNB N/A
- 52 Week Low
- NBY $0.36
- MTNB $0.48
- 52 Week High
- NBY $9.10
- MTNB $9.70
- Technical
- Relative Strength Index (RSI)
- NBY 50.71
- MTNB 64.44
- Support Level
- NBY $0.56
- MTNB $0.54
- Resistance Level
- NBY $0.60
- MTNB $0.60
- Average True Range (ATR)
- NBY 0.04
- MTNB 0.05
- MACD
- NBY 0.01
- MTNB 0.01
- Stochastic Oscillator
- NBY 75.00
- MTNB 100.00
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.